News

PJT Partners Set to Announce Quarterly Results Soon

PJT Partners Set to Announce Quarterly Results Soon

PJT Partners Set to Announce Quarterly Results Soon

PJT Partners (NYSE: PJT) is gearing up to release its quarterly earnings report, and investors are keen to learn how the company has been performing. The anticipated announcement will take place shortly, and expectations are high.

Analysts are estimating that PJT Partners will report an earnings per share (EPS) of approximately $0.93. Investor sentiment is optimistic as they await news not only about earnings but also about forecasts for the upcoming quarter.

It's crucial for new investors to realize that while the reported earnings are significant, it is often the guidance provided during the earnings call that causes the most substantial market reactions.

Reviewing Previous Earnings Performance

Reflecting on the last quarter, PJT Partners surprised many by reporting an EPS that exceeded expectations by $0.50. This strong performance drove a 2.13% increase in share price the day following the announcement.

Here’s a summary of PJT Partners's recent earnings history and the corresponding stock price changes:

Quarterly EPS Overview

Quarter: Q2 2024 | EPS Estimate: 0.69 | EPS Actual: 1.19 | Price Change %: 2.0%
Quarter: Q1 2024 | EPS Estimate: 0.45 | EPS Actual: 0.98 | Price Change %: 1.0%
Quarter: Q4 2023 | EPS Estimate: 0.88 | EPS Actual: 0.96 | Price Change %: -3.0%
Quarter: Q3 2023 | EPS Estimate: 0.49 | EPS Actual: 0.78 | Price Change %: 3.0%

PJT Partners's Stock Market Performance

As of October 25, shares of PJT Partners were trading at $139.64, marking a significant gain of 81.04% over the past 52 weeks. This robust performance is a positive indication for long-term shareholders as they approach this next earnings report.

Investors seeking updates and tracking opportunities can stay tuned for detailed information about all earnings releases related to PJT Partners.

Frequently Asked Questions

1. When will PJT Partners release its earnings report?

PJT Partners is set to announce its quarterly earnings report soon.

2. What is the expected EPS for PJT Partners?

The anticipated earnings per share (EPS) for PJT Partners is $0.93.

3. How did PJT Partners perform in the last quarter?

In the last quarter, PJT Partners exceeded EPS expectations by $0.50, resulting in a 2.13% jump in share price.

4. What is the stock price trend for PJT Partners?

The shares of PJT Partners have increased by 81.04% over the past year, showcasing robust long-term growth.

5. Why is market guidance important for PJT Partners?

Market guidance provides investors with insight into the company's future performance, often influencing stock price reactions significantly.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 345

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Korean 'Glocal' Districts Entice U.S. Tourists with Local Flavor

Updated Category News Views 97

Gwangju's Dongmyeong-dong is like the neighborhood artists and hipsters flock to in New York—except it’s got a Korean twist. Nestled in the Jeonnam region, this place is hot on American tourists' radar for its spicy mix of local culture, unique eats, and shops that scream individuality. It's becoming a magnet for folks who want to get a taste of Korean life but with a...

Continue Reading
Veterinary Stories Transform Pet Care in New Docuseries

Updated Category News Views 82

Peeling Back the Scrubs: Hidden Heroes in Vet Medicine Everyone's all-hands-on-deck when it's your furball on the line, but how much do you really know about what happens in those vet offices? Finally, National Veterinary Associates (NVA) is unzipping that mystery with a no-bones-about-it docuseries, Advancing Veterinary Medicine: Our Stories, right out of Austin, Texas....

Continue Reading
AI Tool Identifies PTSD in ER: Game-changer?

Updated Category News Views 65

Pushing Boundaries: AI and Emergency Room Narratives When you think about the chaos of an emergency room, PTSD might not be the first thing that comes to mind. But for the folks developing cutting-edge AI at NYU Langone Health, it's a crucial window of opportunity. Enter PREVIA, an AI tool that’s been tapping into patients’ narratives to pinpoint PTSD risks with...

Continue Reading
TalentNeuron and CodeSignal Team Up: Impact on Workforce

Updated Category News Views 55

Skills Intelligence Takes Center Stage There's a fresh breeze blowing through the workforce planning domain, thanks to the newly expanded partnership between TalentNeuron and CodeSignal. They've strapped together their expertise to craft what's now touted as the most comprehensive skills intelligence available to organizations. A claim big enough to make us stop,...

Continue Reading
Hyperscale Data Plans Major Stock Exchange Deal

Updated Category News Views 46

Hyperscale's Bold Move: Exchange Offer Hits the Market Man, when a company believes its market value is out of whack, you get moves like this. Hyperscale Data, strutting under ticker symbol NYSE:GPUS, is swinging for the fences with an exchange offer, aiming to mop up $50 million worth of its common stock with a sweet deal that’s sure to grab any investor's attention....

Continue Reading
Terminales Portuarios Euroandinos Paita Seeks Consent to Amend Notes

Updated Category News Views 0

Initiating Amendments for Flexibility Terminales Portuarios Euroandinos Paita S.A., based over in Piura, Peru, has started the process of soliciting consents from holders of its 8.125% Series 2012-1 Senior TPE Secured Notes due 2037. These folks are looking to tweak the indenture tied up with Citibank N.A., trying to get some extra wiggle room in their operations. We’re...

Continue Reading
PharmaBlock Forum: Strategic CMC Moves Crucial for Biotech

Updated Category News Views 83

CMC Strategies: The Unsung Hero in Biotech Development Ah, the world of biotech, where one day you're a hero in the lab, and the next you're scrambling to make sense of chemistry, manufacturing, and controls (CMC). It's high time folks started realizing that CMC isn't just procedural drudgery—it's the backbone of making a promising drug go global. That's what the...

Continue Reading
Laboratoires Pierre Fabre and XtalPi Unite for AI-Driven Drug Hunt

Updated Category News Views 191

An Unexpected Turn in the Drug Discovery Arena It's not every day that you see a historic French pharma powerhouse and a cutting-edge Chinese tech firm join forces. On one side, we've got Laboratoires Pierre Fabre, steeped in the history and nitty-gritty of clinical drug development. On the other, we’ve got XtalPi Holdings Limited (2228.HK), bringing their high-tech AI...

Continue Reading
Expedera Teams Up with Cadence for Edge AI Supercharge

Updated Category News Views 36

A New Power Couple in AI Expedera and Cadence have decided to stir up the edge AI waters with their latest collaboration. By linking Expedera's Origin™ Evolution NPU with Cadence's Tensilica NeuroEdge 130 AI Co-Processor, we're looking at a partnership that's hell-bent on redefining efficiency and performance in edge AI systems. Breaking Down the Collaboration This...

Continue Reading

Top 5 Most Recently Viewed Articles

Elutia Marks Milestone with First Patient Implant of EluPro

Updated Category News Views 190

Significant Advancements in Cardiac Technology Elutia Inc. (NASDAQ: ELUT) has made a remarkable impact in the medical technology sector with the successful first patient implant of EluPro, a groundbreaking antibiotic-eluting biologic envelope tailored for cardiac pacemakers and neurostimulators. This achievement marks a pivotal moment for Elutia, a frontrunner in creating...

Continue Reading
Cook Smarts Revolutionizes Meal Planning with New App Release

Updated Category News Views 207

Cook Smarts Unveils Innovative Meal Planning App In a world where managing daily meals can be daunting, Cook Smarts LLC has launched a groundbreaking iOS mobile app designed to transform the meal planning experience. This convenient application aims to cut down on food waste and alleviate the stress connected to daily meal preparations, catering to home cooks seeking an...

Continue Reading
Lottery.com Inc. Takes Steps Towards Compliance with NASDAQ

Updated Category News Views 129

Lottery.com Inc. Faces Compliance Notification from NASDAQ Lottery.com Inc. received an important notification from NASDAQ regarding its financial reporting. This occurrence highlights significant compliance issues faced by many publicly listed companies in today's competitive market. On November 20, the company was informed about a delay in filing the Form 10-Q for the...

Continue Reading
Norris McLaughlin Expands Expertise with New Hires

Updated Category News Views 15

Norris McLaughlin Grows Its Utility Practice In a move that's cooking up interest, Norris McLaughlin, P.A. has decided to beef up its Public Utilities, Telecommunications, and Energy practice. By bringing Martin C. Rothfelder and Bradford M. Stern into the fold, they're not just adding any courtroom rookies. These are seasoned pros whose resumes read like a who's who of...

Continue Reading
Revolutionary Cancer Study by Etcembly and Surrey Researchers

Updated Category News Views 71

Revolutionary Approach to Cancer Treatment Development In an exciting collaboration, British techbio innovator Etcembly is partnering with esteemed researchers and clinicians from the University of Surrey to unveil a pioneering study that holds the potential to redefine the landscape of cancer treatment. This innovative research focuses on analyzing immune cells derived...

Continue Reading